Australia’s trusted immunisation experts
28 June 2024 | NewsCall for participants: new NCIRS study on possible links between genes and adverse events after COVID-19 vaccinationRead the full article
Use of 1 dose of 9vHPV in immunocompetent females and males aged ≥9 years
Coversheet on evidence assessment by ATAGI using the GRADE framework for 1 dose of 9vHPV in immunocompetent females and males aged ≥9 years
Compared against no vaccine/control vaccine/placebo in immunocompetent females and males aged ≥9 years
Compared against 2 or 3 doses of 9vHPV in immunocompetent females and males aged ≥9 years
Note: These GRADE documents should be read as a supplement to the Australian Immunisation Handbook recommendations.
View the HPV disease chapter in the Handbook here